The effects of a nonimmunogenic form of murine soluble interferon-γ receptor on the development of autoimmune diabetes in the NOD mouse

Endocrinology

Volumn 137, Issue 12, 1996, Pages 5567-5575

  Nicoletti, Ferdinando ^a,d   Zaccone, Paola ^b   Di Marco, Roberto ^b   Di Mauro, Maurizio ^b   Magro, Gaetano ^b   Grasso, Sebastiano ^b   Mughini, Lanfranco ^b   Meroni, Pierluigi ^a   Garotta, Gianni ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c GLAXOSMITHKLINE   (United States)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERFERON RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AN 18; MONOCLONAL ANTIBODY XMG 1.2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETOGENESIS; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0030444632     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.12.8940385     Document Type: Article

References (40)

1. Landolfo S, Garotta G 1991 IFN-gamma. An immunomodulatory and proinflammatory lymphokine. J Immunol Res 9:81-94
2. Bendtzen K 1989 Immune hormones (cytokines) pathogenic role in autoimmune rheumatic diseases and endocrine diseases. Autoimmunity 2:177-189
3. Rabinovitch A 1993 Roles of cytokines in IDDM pathogenesis and islet beta cell destruction. Diabetes Rev 1:215-240
4. Campbell IL, Kay TWH, Oxbrow, Harrison LC 1991 Essential role for interferon gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Whei mice. J Clin Invest 87:739-742
5. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I Bedossa P, Bach JF 1991 Prevention of diabetes in NOD mice treated with antibody to murine IFN-gamma. J Autoimmun 4:237-248
6. Pennline KJ, Roque-Gaffney E, Monahan M 1994 Recombinant human IL-10 prevents the onset of diabetes in nonobese diabetic mouse. Clin Immunol Immunopathol 71:169-175
7. Nicoletti F, Meroni PL, Landolfo S, Gariglio M, Guzzardi S, Barcellini W, Lunetta M, Mughini L, Zanussi C 1990 Prevention of diabetes in BB/Wor rats with monoclonal antibodies against rat gamma interferon. Lancet 336:319
8. Cockfield SM, Ramassar V, Urmson J, Halloran PF 1989 Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma. J Immunol 142:1120-1128
9. Mayes JT, Thistlethwaite Jr JR, Stuart JK, Buckingam MR, Stuart FP 1988 Reexposure to OKT3 in renal allograft recipients. Transplantation 45:349-356
10. Chatenoud L 1993 Humoral immune response against OKT3. Transplant Proc 25:68-74
11. Waldman TA 1991 Monoclonal antibody in diagnosis and therapy. Science 252:1657-1661
12. Isaacs JD, Watts RA Hazleman BL, Hale G, Keogan MT, Cobbold SP, Waldman H 1992 Humanized monoclonal antibody therapy for rheumatoid arthritis. Lancet 340:748-751
13. Gentz R, Hoyes A, Dasulin K, Boy MC, Malucelli M, Founoulakis M, Lahn HW, Ozmen L, Garotta G 1992 Expression of soluble IFN-gamma receptor by recombinant baculovirus. Eur J Biochem 240:545-552
14. Ozmen L, Gribaudo G, Fountoulakis M, Gentz R, Landolfo S, Garotta G 1993 Mouse soluble IFN-gamma receptor as IFN-gamma inhibitor. Distribution, antigenicity and activity after injection in mice. J Immunol 150:2698-2705
15. Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G 1995 Experimental therapy of systemic lupus erythematosus: the treatemtn of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur J Immunol 25:6-12
16. Cherwinski HM, Schumacher JH, Brown K, Mosmann TR 1987 Two types of mouse helper T cell clones. III. Further differences in lymphokine synthesis between TH1 and TH2 clones revealed by RNA hybridization, functionally monospecific bioassays and monoclonal antibodies. J Exp Med 166:1229-1244
17. Prat M, Gribaudo G, Comoglio P, Cavallo G, Landolfo S 1984 Monoclonal antibodies against murine gamma-interferon. Proc Natl Acad Sci USA 81:4515-4521
18. Fountoulakis M, Schlager EJ, Gentz R, Juranville JF, Manneberg M, Ozmen L, Garotta G 1991 Purification and biochemical characterization of a soluble mouse Interferon-gamma receptor produced in insect cells. Eur J Biochem 198:441-448
19. Pozzilli P, Signore A, Williams AJ, Beales PE NOD mouse colonies around the world: recent facts and figures. Immunol Today 14:193-196
20. Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni PL 1994 Protection from experimental autoimmune diabetes in NOD mouse with soluble IL-1 receptor. Eur J Immunol 24:1843-1847
21. Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, Kennedy MK 1991 Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J Immunol 146:2983-2989
22. Wooley PH, Dutcher J, Widmer MB, Gillis S 1993 Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 151:6602-6607
23. Nicoletti F, Zaccone P, Magro G, Barcellini W, Cavallaro V, Belli G, Cocuzza C, Di Marco R, Meroni PL 1994 The effects of thymopentin on the development of SLE-like syndrome in the MRL/Ipr-lpr mouse. Stand J Immunol 40:549-556
24. Wicker L, Miller BJ, Mullen Y 1986 Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:855-862
25. Ozmen L, Fountoulakis M, Garotta G 1992 A novel solid-phase test to study the binding of IFN-gamma to its receptor. J Immunol Methods 147:261-267
26. Williams RO, Mason LJ, Feldmann M, Maini RN 1994 Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 91:2762-2766
27. Nicoletti F, Meroni PL, Di Marco R, Grasso S, Barcellini W, Borghi MO, Lunetta M, Mughini L, Menta R, Schorlemmer HU, Zanussi C 1992 The effects of deoxyspergualin on the development of diabetes in diabetes-prone BB rats. Scand J Immunol 36:415-420
28. Rabinovitch A 1994 Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation. Diabetes 43:613-621
29. Harada M, Makino S 1984 Promotion of spontaneous diabetes in non obese diabetes prone-mice by cyclophosphamide. Diabetologia 27:604-606
30. Yasunami R, Bach JF 1988 Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18:481-484
31. Charlton B, Bacelj A, Slattery RM, Mandel TE 1989 Cyclophosphamide-induced diabetes in NOD/WHEI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 38:441-447
32. Finck BK, Chan B, Wofsy D 1994 Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 94:585-591
33. Kurasawa K, Sakamoto A, Maeda T, Sumida T, Ito I, Tomioka H, Yoshida S, Koike T 1993 Short-term administration of anti-L3T4 MoAb prevents diabetes in NOD mice. Clin Exp Immunol 91:376-380
34. Baxter AG, Koulmanda M, Mandel TE 1991 High and low diabetes incidence nonobese diabetic (NOD) mice: origins and characterisation. Autoimmunity 9:61-67
35. Jacob CO, Aiso S, Schreiber RD, McDevitt HO 1992 Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development. Int Immunol 4:611-614
36. Kelley VE, Gaulton GN, Hattori M, Ikegami H, Eisenbarth G, Strom TB 1980 Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol 150:59-61
37. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW 1994 Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p.55. Blood 83:113-118
38. Mihara M, Ikuta M, Koishihara Y, Oshugi Y 1991 Interleukin-6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis. Eur J Immunol 21:2327-2331
39. Garotta G, Ozmen L, Fountoulakis M, Dembic Z, Van Loon APGM, Stueber D 1990 Human IFN-gamma receptor: mapping of epitopes recognized by neutralizing antibodies using native and recombinat proteins. J Biol Chem 265:6908-6915
40. Kurschner C, Ozmen L, Garotta G, Dembic Z 1992 IFN-gamma receptor-Ig fusion proteins. Half-life, immunogenicity and in vivo activity. J Immunol 149:4096-4100